申请人:The United States of America as represented by the Secretary of the Navy
公开号:US07375221B1
公开(公告)日:2008-05-20
The present invention includes a method of making of azidoaminotriazole (5-azido-2H-[1,2,4]triazol-3-ylamine), nitrosoguanazine dimer (N3-[(1E)-3-(4,5-diamino-4H-1,2,4-triazol-3-yl)-1,2-dioxidotriaz-1-enyl]-4H-1,2,4-triazole-3,4,5-triamine), novel nitrosoguanazine salts, azidonitraminotriazole/salts and the making of azidonitraminotriazole and salts, and novel metal complexes of an azidonitramine (4,6-diazido-N-nitro-1,3,5-triazin-2-amine) and the making of these metal complexes of this azidonitramine. Azidoaminotriazole, nitrosoguanazine, and azidonitramine compounds, their intermediates, and their salts may generally relate to energetic compounds, while nitrosoguanazine compounds and their metal salts may also have commercial potential in biomedical and pharmaceutical applications.
本发明涉及制备偶氮胍二聚体(N3-[(1E)-3-(4,5-二氨基-4H-1,2,4-三唑-3-基)-1,2-二氧代三唑-1-烯基]-4H-1,2,4-三唑-3,4,5-三胺), 偶氮氨基三唑(5-偶氮基-2H-[1,2,4]三唑-3-氨基),新型偶氮胍盐,偶氮氨基三唑/盐以及制备偶氮氨基三唑和盐的方法,以及偶氮氨基(4,6-二偶氮基-N-硝基-1,3,5-三嗪-2-胺)的新型金属配合物和制备这些金属配合物的方法。偶氮胍二聚体,偶氮氨基三唑和偶氮氨基化合物,它们的中间体和盐通常与高能化合物有关,而偶氮胍化合物及其金属盐在生物医药应用方面也可能具有商业潜力。